神经系统疾病中的帕尔瓦尔胺神经元功能障碍:专注于和阿尔茨海默病
1Department of Anatomy, School of Biomedical Sciences, Brain Health Research Centre, University of Otago, Dunedin 9016, New Zealand.
International journal of molecular sciences
|May 25, 2024
概括
功能障碍的帕瓦胺 (PV+) 内神经元破坏大脑激发/抑制平衡,导致和认知衰退. 准这些神经元为和阿尔茨海默病 (AD) 提供了治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 细胞神经科学 细胞神经科学
- 系统神经科学 系统神经科学
背景情况:
- 帕瓦胺表达 (PV+) GABAergic 内神经元对于大脑功能至关重要,调节刺激和同步.
- 他们的功能障碍与过度兴奋,和认知障碍有关,特别是在衰老和阿尔茨海默病 (AD) 中.
研究的目的:
- 审查功能障碍的PV + 内神经元在和认知衰退中的作用.
- 探索PV+内部神经元作为神经系统疾病的治疗点.
主要方法:
- 对PV+内部神经元功能和功能障碍的现有文献的综述.
- 讨论最近的光遗传学和化学遗传学研究,在动物模型中操纵PV+内部神经元.
主要成果:
- PV+内部神经元缺陷会破坏刺激/抑制平衡,导致和认知障碍.
- 在动物模型中,对PV+ 内神经元的选择性操纵可以控制发作并恢复神经活动平衡.
结论:
- 功能障碍的PV + 内神经元与和认知衰退有关,包括AD.
- 针对PV + 内神经元,为这些疾病提供了一个有前途的治疗策略.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
Antiepileptic Drugs: Glutamate Antagonists
320
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
320
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Arteries of the Lower Limbs
188
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
188
Antiepileptic Drugs: GABAergic Pathway Potentiators
385
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385


